HyTdb

NH-11

HyT-021 | Adamantane | Published 2023.12.12

Basic Information

MS7
linker
Adamantane
POINAMPT — Nicotinamide phosphoribosyltransferase
Degradation PathwayUbiquitin-Proteasome Pathway
Published2023.12.12

Remarks

Chemical Identifiers

SMILESO=S(C(C=C1)=CC=C1NC(NCC2=CC=CN=C2)=S)(N3CCN(C(CCCCCCCC(NCC4(C5)C[C@@H](C6)CC5C[C@H]6C4)=O)=O)CC3)=O
Molecular FormulaC37H52N6O4S2
InChIInChI=1S/C37H52N6O4S2/c44-34(40-27-37-22-29-19-30(23-37)21-31(20-29)24-37)8-4-2-1-3-5-9-35(45)42-15-17-43(18-16-42)49(46,47)33-12-10-32(11-13-33)41-36(48)39-26-28-7-6-14-38-25-28/h6-7,10-14,25,29-31H,1-5,8-9,15-24,26-27H2,(H,40,44)(H2,39,41,48)/t29-,30-,31?,37?/m0/s1
InChI KeyRZGDITMIPZTSJL-PYOQVAFQSA-N
IUPAC NameNA
PubChem CIDNA

Basic Properties

TPSAComputing…
RingsComputing…
FSP3Computing…
Heavy Atom CountComputing…

Lipinski RO5

RO5 ViolationComputing…
MWComputing…
ClogPComputing…
HBDComputing…
HBAComputing…
RBComputing…

Hydrophobic Tag Properties

Tag Structure
Tag TypeAdamantane
Tag SMILESC1(CC(C2)C3)CC2CC3C1
Tag ClogP5.022
HydrophobicityHigh(ClopP>5)

Mechanism of Action

POI (Protein of Interest)

POI NameNicotinamide phosphoribosyltransferase
GeneNAMPT
UniProt IDP43490

Amino Acid Sequence

MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHH

3D Structure (/structures/AF-P43490-F1-model_v6.cif)

Loading /structures/AF-P43490-F1-model_v6.cif …

Function

Catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway. The secreted form behaves both as a cytokine with immunomodulating properties and an adipokine with anti-diabetic properties, it has no enzymatic activity, partly because of lack of activation by ATP, which has a low level in extracellular space and plasma. Plays a role in the modulation of circadian clock function. NAMPT-dependent oscillatory production of NAD regulates oscillation of clock target gene expression by releasing the core clock component: CLOCK-BMAL1 heterodimer from NAD-dependent SIRT1-mediated suppression.

Degradation Pathway

NameUbiquitin-Proteasome Pathway
Assay MethodWB;RT-qPCR

Mechanism

The ubiquitin-proteasome pathway (UPP) constitutes the principal pathway for protein degradation in eukaryotic cells, mediating the breakdown of target proteins through ubiquitin tagging and subsequent proteasomal degradation. In an ATP-dependent manner, the ubiquitin-activating enzyme (E1) activates ubiquitin (Ub) and conjugates it to a ubiquitin-conjugating enzyme (E2). E3 ligase subsequently catalyzes the transfer of Ub to the target protein, leading to the formation of a polyubiquitin chain that completes the ubiquitination mark. The 19S regulatory particle of the 26S proteasome recognizes this ubiquitination signal and, after deubiquitination, mediates the ATP-dependent delivery of the substrate into the 20S proteasome for degradation.

Description

Compound NH-11 possessed the highest capacity for NAMPT degradation and was selected for further mechanism and antitumor activity evaluations. In eukaryotic cells, damaged proteins can be degraded by proteasomes or lysosomes [35,36]. To investigate the potential degradation mechanism of NH-11, we performed rescue assays. The K562 cells was co-treated with NH-11 and lysosomal inhibitor bafilomycin A1 (Baf A1) [37], or ubiquitin (Ub) proteasome inhibitors MG132 [38], carfilzomib [39]. It was found that the MG132 and carfilzomib largely abolished NH-11-induced NAMPT degradation (Fig. 3E), indicating that NH-11 mediated the degradation of NAMPT via the Ub-proteasome system (UPS).

Activity Data

TypeDC50
Value3.18 μM
POI NameSRC-1
Cell LineK562
Cell Line IDCVCL_0004
Assay MethodWB
Reference10.1016/j.cclet.2023.109392

Description

NH-11 dose-dependently induced NAMPT degradation with DC 50 values of 3.18 μmol/L (K562), 6.05 μmol/L (HL60) and 7.32 μmol/L (Jurkat), respectively (Figs. 3A and B)

TypeDC50
Value6.05 μM
POI NameSRC-1
Cell LineHL60
Cell Line IDCVCL_0002
Assay MethodWB
Reference10.1016/j.cclet.2023.109392

Description

NH-11 dose-dependently induced NAMPT degradation with DC 50 values of 3.18 μmol/L (K562), 6.05 μmol/L (HL60) and 7.32 μmol/L (Jurkat), respectively (Figs. 3A and B)

TypeDC50
Value7.32 μM
POI NameSRC-1
Cell LineJurkat
Cell Line IDCVCL_0065
Assay MethodWB
Reference10.1016/j.cclet.2023.109392

Description

NH-11 dose-dependently induced NAMPT degradation with DC 50 values of 3.18 μmol/L (K562), 6.05 μmol/L (HL60) and 7.32 μmol/L (Jurkat), respectively (Figs. 3A and B)

TypeIC50
Value0.73±0.31 μM
POI NameSRC-1
Cell LineK562
Cell Line IDCVCL_0004
Assay MethodCCK8 assay
Reference10.1016/j.cclet.2023.109392

Description

Given the potent NAMPT inhibition activity and degradation efficiency of NH-11, its antiproliferative activity against leukemia cell lines were also investigated by using a cell counting kit-8 (CCK8) assay. The results revealed that NH-11 showed potent antiproliferative activity against K562, Jurkat and HL60 cells with IC50 value of 0.73 ± 0.31, 0.03 ± 0.01, and 0.95 ± 0.38 μmol/L, respectively (Fig. S2 and Table S2 in Supporting information).

TypeIC50
Value0.03±0.01 μM
POI NameSRC-1
Cell LineJurkat
Cell Line IDCVCL_0002
Assay MethodCCK8 assay
Reference10.1016/j.cclet.2023.109392

Description

Given the potent NAMPT inhibition activity and degradation efficiency of NH-11, its antiproliferative activity against leukemia cell lines were also investigated by using a cell counting kit-8 (CCK8) assay. The results revealed that NH-11 showed potent antiproliferative activity against K562, Jurkat and HL60 cells with IC50 value of 0.73 ± 0.31, 0.03 ± 0.01, and 0.95 ± 0.38 μmol/L, respectively (Fig. S2 and Table S2 in Supporting information).

TypeIC50
Value0.95±0.38 μM
POI NameSRC-1
Cell LineHL60
Cell Line IDCVCL_0065
Assay MethodCCK8 assay
Reference10.1016/j.cclet.2023.109392

Description

Given the potent NAMPT inhibition activity and degradation efficiency of NH-11, its antiproliferative activity against leukemia cell lines were also investigated by using a cell counting kit-8 (CCK8) assay. The results revealed that NH-11 showed potent antiproliferative activity against K562, Jurkat and HL60 cells with IC50 value of 0.73 ± 0.31, 0.03 ± 0.01, and 0.95 ± 0.38 μmol/L, respectively (Fig. S2 and Table S2 in Supporting information).

Disease Information

DiseaseICD-11Source
Chronic myeloid leukaemia2B33.2Cell Line Origin
Acute myeloblastic leukemia with maturation2A60.32Cell Line Origin
Early T-cell precursor acute lymphoblastic leukemiaXH8F29Cell Line Origin
AgingMG2AGene-Disease Association
Gestational DiabetesJA63.2Gene-Disease Association
Type 2 Diabetes Mellitus5A11Gene-Disease Association
Osteoid OsteomaXH61J9Gene-Disease Association
Pellagra5B5C.0Gene-Disease Association
CholecystitisDC12Gene-Disease Association
Diabetes Mellitus5A14Gene-Disease Association